NCT01799538 2026-03-11
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Phase 1/2 Recruiting
Clinical Trials
8 trialsNCT00001465 2026-02-20
Study of the Disease Process of Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Recruiting
NCT03304678 2026-02-18
Discovery of Sirolimus Sensitive Biomarkers in Blood
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00366509 2021-08-02
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
National Institutes of Health Clinical Center (CC)
Completed
NCT00552955 2019-03-06
Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
National Institutes of Health Clinical Center (CC)
Completed
NCT00005486 2016-02-18
Lymphangioleiomyomatosis (LAM) Registry
National Heart, Lung, and Blood Institute (NHLBI)
Completed
NCT00005906 2010-04-30
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00001869 2008-03-04
Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)
National Institutes of Health Clinical Center (CC)
Completed